This study will occur in two phases.
Phase 1 will involve refining Cognitive Processing Therapy Lived Experience Adapted Protocol (CPT-LEAP) and includes beta testing of CPT-LEAP (n=6).
Phase 2 will involve a pilot RCT in which participants (n=52) will be randomized (1:1) to standard CPT or CPT-LEAP. The investigators anticipate 26 participants will be enrolled in each treatment arm.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Current diagnosis of PTSD
Self-identification as a sexual or gender minority (SGM) individual
Endorsement of SGM stress experiences with moderate distress
For patients who take psychiatric medication, stable dose one month prior to enrollment
Reside in Massachusetts.
You may not be if
Current active suicidal or homicidal ideation with intent or plan
Unstable bipolar disorder/current mania
Unstable psychotic disorder/current psychosis
Current severe substance use that warrants immediate medical attention
Cognitive impairment or organic disorder (e.g., advanced dementia, severe traumatic brain injury) that impairs ability to complete CPT procedures
Past completion of CPT or current trauma-focused treatment
Unwillingness to consent to audio or video recording of assessment and treatment sessions
Clareo Health | Cognitive Processing Therapy for Posttraumatic Stress Disorder and Co-occurring Lived Experience Stress
